Verastem Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress

BOSTON--(BUSINESS WIRE)--Aug 8, 2023--

Related Keywords

United States ,Massachusetts ,Karin Tollefson ,Robert Gagnon ,Brian Stuglik ,Dan Calkins ,Elisa Buffington ,Dan Paterson ,Company Board Of Directors ,Commercialization Committee ,Amgen ,Corporate Communications ,Pancreatic Cancer Action Network Pan ,Exchange Commission ,Company Phase ,Drug Administration ,Foundation Inc ,Chugai Pharmaceutical Co Ltd ,European Network Of Gynaecological Oncological Trial ,Chief Executive Officer ,Grade Serous Ovarian Cancer ,European Network ,Gynaecological Oncological Trial ,American Society ,Clinical Oncology Meeting ,Breakthrough Therapy Designation ,Pancreatic Cancer Action Network ,Chief Operating Officer ,Verastem Oncology ,Senior Vice President ,Global Medical Affairs ,Breakthrough Therapy ,Annual Report ,Consolidated Statements ,Business Wire ,Region ,